These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23843692)

  • 21. Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress.
    Palladini G; Di Pasqua LG; Berardo C; Siciliano V; Richelmi P; Perlini S; Ferrigno A; Vairetti M
    Can J Gastroenterol Hepatol; 2019; 2019():5413461. PubMed ID: 30854350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yellow loosestrife (Lysimachia vulgaris var. davurica) ameliorates liver fibrosis in db/db mice with methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis.
    Son YJ; Jung DS; Shin JM; Kim M; Yoo G; Nho CW
    BMC Complement Med Ther; 2021 Jan; 21(1):44. PubMed ID: 33494735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldose reductase is involved in the development of murine diet-induced nonalcoholic steatohepatitis.
    Qiu L; Lin J; Ying M; Chen W; Yang J; Deng T; Chen J; Shi D; Yang JY
    PLoS One; 2013; 8(9):e73591. PubMed ID: 24066058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
    Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
    Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
    Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
    BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Betaine treatment decreased oxidative stress, inflammation, and stellate cell activation in rats with alcoholic liver fibrosis.
    Bingül İ; Başaran-Küçükgergin C; Aydın AF; Çoban J; Doğan-Ekici I; Doğru-Abbasoğlu S; Uysal M
    Environ Toxicol Pharmacol; 2016 Jul; 45():170-8. PubMed ID: 27314760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators.
    Henry PJ; Drummer OH; Horowitz JD
    Br J Pharmacol; 1989 Nov; 98(3):757-66. PubMed ID: 2511992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats.
    Ebrahimkhani MR; Kiani S; Oakley F; Kendall T; Shariftabrizi A; Tavangar SM; Moezi L; Payabvash S; Karoon A; Hoseininik H; Mann DA; Moore KP; Mani AR; Dehpour AR
    Gut; 2006 Nov; 55(11):1606-16. PubMed ID: 16543289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
    Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
    Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
    Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
    Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
    Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis.
    Ibañez P; Solis N; Pizarro M; Aguayo G; Duarte I; Miquel JF; Accatino L; Arrese M
    J Gastroenterol Hepatol; 2007 Jun; 22(6):846-51. PubMed ID: 17565640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of Shaoqiduogan on MMP-13, TIMP-1 expression in liver and hepatic stellate cells of hepatic fibrosis rats].
    Sun W; Gui S; Wu L; Wang H; Wei W
    Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1447-51. PubMed ID: 20822018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eicosapentaenoic acid attenuates progression of hepatic fibrosis with inhibition of reactive oxygen species production in rats fed methionine- and choline-deficient diet.
    Kajikawa S; Imada K; Takeuchi T; Shimizu Y; Kawashima A; Harada T; Mizuguchi K
    Dig Dis Sci; 2011 Apr; 56(4):1065-74. PubMed ID: 20848203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic changes in the expression of matrix metalloproteinases and their inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in rats.
    Xu GF; Li PT; Wang XY; Jia X; Tian DL; Jiang LD; Yang JX
    World J Gastroenterol; 2004 Dec; 10(24):3621-7. PubMed ID: 15534918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel oral plasminogen activator inhibitor‑1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats.
    Noguchi R; Kaji K; Namisaki T; Moriya K; Kawaratani H; Kitade M; Takaya H; Aihara Y; Douhara A; Asada K; Nishimura N; Miyata T; Yoshiji H
    Mol Med Rep; 2020 Oct; 22(4):2948-2956. PubMed ID: 32945412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model.
    Machado MV; Kruger L; Jewell ML; Michelotti GA; Pereira Tde A; Xie G; Moylan CA; Diehl AM
    Dig Dis Sci; 2016 Jan; 61(1):137-48. PubMed ID: 26403427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-acetylcysteine attenuates oxidative stress and liver pathology in rats with non-alcoholic steatohepatitis.
    Thong-Ngam D; Samuhasaneeto S; Kulaputana O; Klaikeaw N
    World J Gastroenterol; 2007 Oct; 13(38):5127-32. PubMed ID: 17876880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.